BSc (Hons), PMP, ASQ C.PGMP

Mark is an executive level project manager/researcher/consultant with a proven track record of designing and effecting positive change in international life science companies. Mark graduated from the University of Sydney in Science (Hons) majoring in Pharmacology and Biochemistry in 1986. He also holds certifications as a Project Management Professional (PMP) from PMI and from the American Society of Quality in Pharmaceutical GMP. He has over 30 yrs experience in Research and Development of Pharmaceutical products and Medical Devices. His early career was spent at the University of Sydney and Royal Prince Alfred Hospital (RPAH) Liver Transplant Unit where he lead a team that developed the first Australian Bio-artificial Liver, trialed in humans with liver failure. As part of his work there he also worked with Dr Kelly to describe many new biologically active isoflavones derived from dietary sources.

He joined Novogen Ltd in 1995 and became an early employee of their US subsidiary in 1998, when he moved there with his wife and family to head Clinical Research and Technical affairs in North America. Mark has held roles of increasing responsibility since, including as a project leader for Deloitte Consulting and Quintiles IMS, advising both large and small clients in medical and clinical research, product approval and launch, professional relationship management, safety surveillance, selection and management of strategic partners and GxP compliant systems.